Dr. Bakouny on the Rate of Disease Progression in Sarcomatoid Carcinoma

In Partnership With:

Partner | Cancer Centers | <b>Dana-Farber Cancer Institute</b>

Ziad Bakouny, MD, MSc, discusses the rate of disease progression in sarcomatoid carcinoma.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Ziad Bakouny, MD, MSc, postdoctoral genitourinary oncology research fellow, Dana-Farber Cancer Institute, discusses the rate of disease progression in sarcomatoid carcinoma.

    Despite recent advances in the sarcomatoid carcinoma armamentarium with therapies​, such as ​the introduction of checkpoint inhibitors, patients with sarcomatoid carcinoma tend to progress very rapidly, says Bakouny.

    As such, it ​is important to note that ​patients' tumors may develop ​into a more severe and symptomatic disease presentation if patientsdo not respond to therapy, ​Bakouny explains.

    In the clinical setting, nurses tend to be sensitive to the risk of disease progression among patients with sarcomatoid carcinoma, Bakouny concludes.


    x